Amgen Knocks Roche In Early Round Of EPO Court Fight
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.